Phylogenetic analysis of env, gag, and tat genes of HIV type 1 detected among the injecting drug users in West Bengal, India

AIDS Research and Human Retroviruses

Volumn 22, Issue 12, 2006, Pages 1293-1299

  Mullick, Ranajoy ^a   Sengupta, Satarupa ^a   Sarkar, Kamalesh ^a   Saha, M K ^a   Chakrabarti, Sekhar ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; DRUG DEPENDENCE; DRUG TRAFFIC; ENVELOPE GENE; EXON; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INDIA; MYANMAR; NEPAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RUSSIAN FEDERATION; SEQUENCE ANALYSIS; SEROPREVALENCE; SEROTYPE; SPAIN; THAILAND; UNINDEXED SEQUENCE; VIET NAM; VIRUS GENOME; VIRUS STRAIN;

GENES, ENV; GENES, GAG; GENES, TAT; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-1; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; PHYLOGENY; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33846238993     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.1293     Document Type: Article

References (18)

1. UNAIDS, Health Canada, The Open Society Institute, and The Canadian International Development Agency: The Warshaw Declaration: A framework for effective action on HIV/AIDS and injecting drug use. Second International Policy Dialogue on HIV/AIDS, Warshaw, Poland, November 12-14, 2003.
2. Carmen A, Stimson GV, Hickman M, et al.: Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004;18:295-2303.
3. Sarkar S, Mookherjee P, Roy A, et al.: Descriptive epidemiology of intravenous heroin users-a new risk group for transmission of HIV in India. J Infect 1991;23:201-207.
4. Weniger BG, Takebe Y, Ou CY, and Yamazaki S: The molecular epidemiology of HIV in Asia. AIDS 1994;8:13-28.
5. Chakrabarti S, Panda S, Chatterjee A, et al.: HIV-1 subtypes in injecting drug users and their noninjecting wives in Manipur, India. Indian J Med Res 2000;111:189-194.
6. Bhanja P, Sengupta S, Singh NY, et al.: Determination of Gag and Env subtypes of HIV-1 detected among injecting drug users (IDUs) in Manipur, India: Evidence for intersubtype recombination. Virus Res 2005;114:149-153.
7. Mandai D, Jana S, Bhattacharya SK, and Chakrabarti S: HIV type 1 subtypes circulating in eastern and northeastern regions of India. AIDS Res Hum Retroviruses 2002;18:1219-1227.
8. Panda S, Kumar MS, Lokabiraman S, et al.: Risk factors for HIV infection in injecting drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr 2005;39:9-15.
9. Pal BB, Khuntia HK, Acharya AS, and Chhotray GP: Drug abusers-a new high risk population for HIV infection in Orissa, Indian. J Med Microbiol 2003;21:262-264.
10. Sengupta S, Jana S, Roy P, Sarkar K, Bhattacharya SK, and Chakrabarti S: Phylogenetic analysis of gag p24-p7 region of HIV-1 detected among female sex workers in Calcutta, India. J Clin Microbiol 2005;43:5787-5791.
11. Sarkar K, Mitra S, Bal B, et al.: Rapid spread of hepatitis C and syringe needle exchange programme in Kolkata, India. Lancet 2003;361:1301-1302.
12. Sarkar K, Bal B, Mukherjee R, et al.: Epidemic of HIV coupled with HCV among injecting drug users of Himalayan West Bengal, eastern-India, bordering Nepal, Bhutan and Bangladesh. J Subst Use Misuse 2005;41:1-12.
13. Sakar K, BaI B, Mukherjee R, et al.: Cross border HIV epidemic among injecting drug users of Himalayan West Bengal. Eur J Epidemiol 2005;20:373-374.
14. Boyam A: Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968;21:77-81.
15. Heyndrickx L, Janssens W, Zekeng L, et al.: Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J Virol 2000;74:363-370.
16. Kumar S, Tamura K, Jacobsen IB, et al.: MEGA2: Molecular evolutionary genetics analysis software. Bioinformatics 2001;17: 1244-1245.
17. Fareedi M and Lepcha PD: Area and Issue Profile of Darjeeling-a research report, Darjeeling, India. 2002;77-78.
18. Oelrichs RB, Shreshta IL, Anderson DA, et al.: The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity. J Virol 2000;74:1149-1157.